(Q44796550)

English

Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan

scientific article published in March 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Helicobacter pylori

0 references

author name string

Suzuki J

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Mine T

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Kobayasi I

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Fujita T

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

59-63

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Antibacterial treatment of gastric ulcers associated with Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

In vitro selection of resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.1998.08021.X

21 January 2018

Identifiers

10.1046/J.1523-5378.1998.08021.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44796550&oldid=2042162518"